Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Asset / Drug

Medline

Drug and asset intelligence for Medline with 6 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
4
Catalysts
2
Stage
Development stage unavailable

Recent signals(4)

StrategyAugust 4, 2026

Medline Issues Correction for Convenience Kits Containing Recalled Lidocaine and Bupivacaine

Medline is removing recalled Lidocaine Hydrochloride and Bupivacaine Hydrochloride from convenience kits.

RegulatoryJuly 10, 2026

FDA Alerts on Non-Sterile BD ChloraPrep Applicators in Medline Convenience Kits

The FDA has issued an alert regarding potential sterility issues with BD ChloraPrep Applicators in Medline's Convenience Kits.

StrategyJune 22, 2026

Medline Issues Correction for Bupivacaine Hydrochloride Kits

Medline is recalling convenience kits that contain Huons Bupivacaine Hydrochloride in Dextrose Injection due to safety concerns.

RegulatoryJune 19, 2026

Medline Industries Expands Catheter Recall Due to Infection Risk

Medline Industries has expanded a recall of reprocessed electrophysiology and ultrasound catheters due to potential contamination risks.

Upcoming milestones

No catalysts indexed for this entity yet.

Related catalysts(2)

Topline Data

— Medline

July 10, 2026 · N/A

Topline Data

— Medline

June 22, 2026 · N/A

Indications

No related entities indexed yet.

Therapeutic areas

Anesthesia →
Anesthesia · Local Anesthetics →
Cardiology →
Catheters →
Infection Control →
Infection Control · Medical Devices →
Local Anesthetics →
Medical Devices →
Pain Management →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.